AU4391199A - Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose - Google Patents

Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose

Info

Publication number
AU4391199A
AU4391199A AU43911/99A AU4391199A AU4391199A AU 4391199 A AU4391199 A AU 4391199A AU 43911/99 A AU43911/99 A AU 43911/99A AU 4391199 A AU4391199 A AU 4391199A AU 4391199 A AU4391199 A AU 4391199A
Authority
AU
Australia
Prior art keywords
ameliorates
cytostatic
antioxidant
glucose
energy composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43911/99A
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau HealthScience SpA
Original Assignee
Sigma Tau HealthScience SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau HealthScience SpA filed Critical Sigma Tau HealthScience SpA
Publication of AU4391199A publication Critical patent/AU4391199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
AU43911/99A 1998-06-30 1999-06-17 Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose Abandoned AU4391199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM98A0433 1998-06-30
IT98RM000433A IT1299197B1 (en) 1998-06-30 1998-06-30 COMPOSITION WITH ANTI-OXIDANT, ANTIPOLIFERATIVE, ENERGETIC ACTIVITY AND SUITABLE TO IMPROVE THE METABOLIC USE OF GLUCOSE.
PCT/IT1999/000176 WO2000000183A2 (en) 1998-06-30 1999-06-17 Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin

Publications (1)

Publication Number Publication Date
AU4391199A true AU4391199A (en) 2000-01-17

Family

ID=11406017

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43911/99A Abandoned AU4391199A (en) 1998-06-30 1999-06-17 Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose

Country Status (5)

Country Link
AR (1) AR019737A4 (en)
AU (1) AU4391199A (en)
IT (1) IT1299197B1 (en)
TN (1) TNSN99138A1 (en)
WO (1) WO2000000183A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (en) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF VASCULOPATHIES, WHICH INCLUDES PROPIONYL L-CARNITINE AND COENZYME Q10.
IT1317035B1 (en) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa SUPPLEMENT WITH ANTIOXIDANT ACTIVITY INCLUDING AN ALKANOILCARNITINE AND AN ASSOCIATION OF POLYPHENOLS EXTRACTED FROM
IT1317036B1 (en) * 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa SUPPLEMENT TO ANTIOXIDANT ACTIVITY INCLUDING AN ALKANOILCARNITINE AND AN ASSOCIATION OF POLYPHENOLS EXTRACTED FROM PLANTS
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
CN1668212A (en) * 2002-07-26 2005-09-14 帝斯曼知识产权资产管理有限公司 Compositions comprising lactoferrin
AU2003279924A1 (en) * 2002-10-11 2004-05-04 Creagri, Inc. Therapeutic combination of carnitine and antioxidant polyphenols
JP2005089384A (en) * 2003-09-18 2005-04-07 Kao Corp Improver of endurance
US7205011B2 (en) 2003-11-14 2007-04-17 Board Of Regents, Acting For And On Behalf Of, University Of Arizona Anti-inflammatory activity of a specific turmeric extract
ES2541911T3 (en) * 2006-06-08 2015-07-28 Iams Europe B.V. Use of at least one polyphenol to stimulate eye health
US20070286925A1 (en) * 2006-06-08 2007-12-13 The Procter & Gamble Company Composition for improving eye health
US9579347B2 (en) 2012-10-04 2017-02-28 Abbott Laboratories Methods for enhancing the effect of EGCg on mitigating skeletal muscle loss

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
WO1997002041A1 (en) * 1995-07-03 1997-01-23 Crandall Wilson T Transdermal and oral treatment of androgenic alopecia
IT1276225B1 (en) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ALKANOYL L-CARNITINE IN ASSOCIATION WITH RESVERATROL OR ITS DERIVATIVES USEFUL FOR
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases

Also Published As

Publication number Publication date
WO2000000183A2 (en) 2000-01-06
TNSN99138A1 (en) 2005-11-10
IT1299197B1 (en) 2000-02-29
AR019737A4 (en) 2002-03-13
WO2000000183A3 (en) 2000-06-29
ITRM980433A1 (en) 1999-12-30
ITRM980433A0 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
AU2041900A (en) Energy application with cooling
AU3813499A (en) The use of dihydropyrimidines as medicaments, and novel substances
EP1072266B8 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
AU2003260342A1 (en) Spirobifluorene derivatives, their preparation and uses thereof
AU1827300A (en) Heat debondable adhesive composition and adhesion structure
AU3177700A (en) Polymers, their preparation and uses
AU3958100A (en) New compounds, their preparation and use
AU3958200A (en) New compounds, their preparation and use
AU3957900A (en) New compounds, their preparation and use
AU763094C (en) Benzimidazoles, production thereof and use thereof as medicaments
AU3033100A (en) Substituted imidazoles, their preparation and use
AU1784301A (en) Topical skin composition
AU4391199A (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose
AU6246199A (en) Human interleukin-b50, therapeutic uses
AU2003246130A1 (en) Heat-storage material, composition therefor, and uses of these
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001260110A1 (en) Novel LHRH-antagonists, Production and Use Thereof as Medicament
AU4779400A (en) Hair-treatment composition
AU5176299A (en) Compound, composition and use
AU6394500A (en) Native cdc25 substrates, compositions and uses related thereto
WO2001022917A3 (en) Effervescent compositions comprising nimesulide
AU1411200A (en) Novel physiologically active substance, process for producing the same and utilization thereof
AU1046799A (en) Compound, composition and use
AU3772800A (en) Diaryl thioethers, compositions and uses thereof
AU2900099A (en) Adhesive composition and precursor thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase